SpringWorks Tangible Book Value Per Share from 2010 to 2024

SWTX Stock  USD 39.39  0.37  0.95%   
SpringWorks Therapeutics Tangible Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Tangible Book Value Per Share will likely drop to 5.53 in 2024. During the period from 2010 to 2024, SpringWorks Therapeutics Tangible Book Value Per Share regression line of annual values had significance of  0.0008 and arithmetic mean of  3.56. View All Fundamentals
 
Tangible Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
9.74303947
Current Value
5.53
Quarterly Volatility
4.94964388
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SpringWorks Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpringWorks Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 923.7 K, Selling General Administrative of 207.4 M or Total Revenue of 5.2 M, as well as many indicators such as Price To Sales Ratio of 444, Dividend Yield of 0.0 or PTB Ratio of 3.86. SpringWorks financial statements analysis is a perfect complement when working with SpringWorks Therapeutics Valuation or Volatility modules.
  
Check out the analysis of SpringWorks Therapeutics Correlation against competitors.
For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

Latest SpringWorks Therapeutics' Tangible Book Value Per Share Growth Pattern

Below is the plot of the Tangible Book Value Per Share of SpringWorks Therapeutics over the last few years. It is SpringWorks Therapeutics' Tangible Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpringWorks Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Tangible Book Value Per Share10 Years Trend
Slightly volatile
   Tangible Book Value Per Share   
       Timeline  

SpringWorks Tangible Book Value Per Share Regression Statistics

Arithmetic Mean3.56
Coefficient Of Variation138.90
Mean Deviation4.46
Median(0.06)
Standard Deviation4.95
Sample Variance24.50
Range13.7377
R-Value0.77
Mean Square Error10.72
R-Squared0.59
Significance0.0008
Slope0.85
Total Sum of Squares342.99

SpringWorks Tangible Book Value Per Share History

2024 5.53
2023 9.74
2022 10.47
2021 8.71
2020 12.87
2019 7.49
2018 -0.87

About SpringWorks Therapeutics Financial Statements

SpringWorks Therapeutics investors use historical fundamental indicators, such as SpringWorks Therapeutics' Tangible Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SpringWorks Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tangible Book Value Per Share 9.74  5.53 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SpringWorks Stock Analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.